DASHENLIN PHARMACEUTICAL GROUP CO., LTD.

Business Segments DaShenLin Pharmaceutical Group Co., Ltd.

Stocks

603233

CNE100002RG2

Drug Retailers

End-of-day quote Shanghai S.E. 15/09/2026			5-day change	1st Jan Change
18.38 ^CNY	+0.71%		+0.77%	+4.31%

02/09	Jefferies Adjusts DaShenLin Pharmaceutical Group's Price Target to 15 Yuan From 12 Yuan, Keeps at Underperform	MT
24/08	DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (CNY)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Retail						1.53TCr	1.92TCr	2.05TCr	2.19TCr	2.23TCr
Gross Profit						-	-	-	-	-
						-	-	-	-	447.54Cr
Franchise and Distribution						100.7Cr	153.86Cr	342.28Cr	394.04Cr	447.54Cr
Gross Profit						-	-	-	-	-
Other Operations						45Cr	44Cr	59Cr	62Cr	64Cr
Unallocated Other Operations						-	-	-	-	-
Gross Profit						-	-	-	-	-
						-	-	-	-	64Cr
						-	-	-	-	2.23TCr

Geographical breakdown of sales (CNY)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
China						1.68TCr	2.12TCr	2.45TCr	2.65TCr	2.75TCr
Total Assets						1.73TCr	2.08TCr	2.41TCr	2.64TCr	2.65TCr
Interest Expense						-21Cr	-23Cr	-24Cr	-25Cr	-19Cr
Income Tax Expense						24Cr	34Cr	40Cr	36Cr	49Cr
D&A						113.92Cr	127.21Cr	142.86Cr	158.35Cr	152.46Cr
CAPEX						-129.49Cr	-103.48Cr	-179.66Cr	-147.58Cr	-49Cr
Net Income						79Cr	103.57Cr	116.65Cr	91Cr	123.52Cr
EBT						104.39Cr	141.49Cr	162.78Cr	133.97Cr	184.94Cr
Operating Income						104.05Cr	142.08Cr	163.18Cr	135.41Cr	185.87Cr

Stock Market
Stocks
603233 Stock
Financials DaShenLin Pharmaceutical Group Co., Ltd.
Business Segments

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!